{
  "ticker": "CRL",
  "year": 2025,
  "quarter": 1,
  "last_updated": "2025-04-19T09:55:23.615356",
  "count": 22,
  "transactions": [
    {
      "id": 272670,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-25",
      "transaction_shares": "430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "54628"
    },
    {
      "id": 315102,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-25",
      "transaction_shares": "430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "54628"
    },
    {
      "id": 272636,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "6075",
      "transaction_price": "165.01",
      "transaction_type": "P",
      "shares_after_transaction": "183639"
    },
    {
      "id": 272651,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "1514",
      "transaction_price": "164.63",
      "transaction_type": "P",
      "shares_after_transaction": "55058"
    },
    {
      "id": 272665,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-02-20",
      "transaction_shares": "4400",
      "transaction_price": "162.50",
      "transaction_type": "S",
      "shares_after_transaction": "20013"
    },
    {
      "id": 315068,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "6075",
      "transaction_price": "165.01",
      "transaction_type": "P",
      "shares_after_transaction": "183639"
    },
    {
      "id": 315083,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-02-20",
      "transaction_shares": "1514",
      "transaction_price": "164.63",
      "transaction_type": "P",
      "shares_after_transaction": "55058"
    },
    {
      "id": 315097,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-02-20",
      "transaction_shares": "4400",
      "transaction_price": "162.50",
      "transaction_type": "S",
      "shares_after_transaction": "20013"
    },
    {
      "id": 272622,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "4057",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "54569"
    },
    {
      "id": 272623,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2025-01-31",
      "transaction_shares": "1758",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9470"
    },
    {
      "id": 272631,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2738",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25259"
    },
    {
      "id": 272637,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "811",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9137"
    },
    {
      "id": 272658,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "19608",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "204391"
    },
    {
      "id": 272660,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2468",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "17297"
    },
    {
      "id": 272685,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2704",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12464"
    },
    {
      "id": 315054,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "4057",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "54569"
    },
    {
      "id": 315055,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2025-01-31",
      "transaction_shares": "1758",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9470"
    },
    {
      "id": 315063,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2738",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25259"
    },
    {
      "id": 315069,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "811",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9137"
    },
    {
      "id": 315090,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "19608",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "204391"
    },
    {
      "id": 315092,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2468",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "17297"
    },
    {
      "id": 315117,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Pease Flavia",
      "reporting_owner_cik": "0001924996",
      "reporting_owner_position": "Corporate Executive VP & CFO",
      "transaction_date": "2025-01-31",
      "transaction_shares": "2704",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12464"
    }
  ]
}